Purchase Expands Linus Health's Cognitive
Assessment Capabilities
BOSTON,
Mass., March 11, 2024 /PRNewswire/ -- Linus
Health, a digital health company enabling early detection of
Alzheimer's and other dementias, today announced it has acquired
Aural Analytics, a leader in clinical-grade speech analytics. The
deal includes Aural Analytics' assets, including its technology and
intellectual property.
With the acquisition of Aural Analytics, Linus Health, the
leader in multimodal cognitive assessments, has added
clinical-grade speech analytics to its platform. This allows Linus
Health to further enable researchers and clinicians to identify
cognitive impairment and better understand the characteristics of
those impairments.
"Our voices reveal essential aspects of our mental state and
brain function. Technology can extract such metrics with exquisite
precision. Aural Analytics has worked in the development and
processing of voice metrics, and integrating them with other
signals captured by the Linus Health platform will substantially
expand our unique brain health assessment capabilities," said
Alvaro Pascual-Leone, MD, PhD, Linus
Health chief medical officer and co-founder.
The acquisition expands Linus Health's operations into the life
sciences industry. Aural Analytics' speech analytics software,
called Speech Vitals, is used by leading healthcare systems and
life science organizations in pharmaceutical research and clinical
trials. It collects samples of speech from patients via app-based
tests and evaluates them to assess cognitive conditions. Speech
Vitals' patented technology has been used to detect multiple
neurological conditions, such as dementia, autism and ALS.
It complements Linus Health's focus on the early detection of
Alzheimer's and other forms of cognitive impairment and dementia by
equipping healthcare providers with digital cognitive assessment
tools, such as the award-winning Digital Clock and Recall (DCR™).
Linus Health had previously tested some aspects of Aural Analytics'
voice analysis in its multimodal algorithms and the combination has
outperformed standard paper-and-pencil tests. The acquisition
allows Linus Health to fully integrate Aural Analytics' technology
for even more accurate performance and develop additional tools for
use by clinicians.
Since its launch in 2015, Arizona-based Aural Analytics has earned a
number of distinctions, including:
- Speech Vitals – ALS technology designated by FDA as a
Breakthrough Device
- Participation in EverythingALS early detection study and more
than 30 other clinical studies
- FDA registration of Speech Vitals as a computerized cognitive
assessment aid
The acquisition of Aural Analytics is the latest strategic move
in Linus Health's construction of the most comprehensive cognitive
and brain health assessment platform. Since 2020 it has acquired
Kinesis Health Technologies, a leader in physical function
assessment for older adults, and Digital Cognition Technologies, a
leader in digital cognitive assessment.
Aural Analytics and Linus Health have participated jointly in
clinical trials, including Bio-Hermes. The experience revealed the
promise of combining their respective offerings into a powerful
multimodal solution. Speech analysis yields valuable insights into
brain function both at a moment in time, and especially over time.
Aural Analytics not only does speech analytics, but has proprietary
technology in the acoustic analysis of voice. Integration of
Aural's analyses into Linus Health's multimodal process-based
assessments yields even deeper insights into brain function and the
ability to identify early brain-related dysfunction quickly.
"Thanks to the nature of software, our platform can distribute
new, advanced and validated digital diagnostics to the market
globally with unprecedented speed," said Linus Health CEO and
Co-Founder David Bates, PhD. "As
with any chronic illness, earlier detection of brain-related
disabilities allows for intervention that can delay, modify or even
prevent progression of the disease. It's why we are engineering the
most inclusive approach to assessing and monitoring brain function,
one that includes speech and movement, in addition to memory and
other neurological functions."
Widespread use of effective screening followed by appropriate
interventions and monitoring will benefit hundreds of millions of
patients worldwide.
Clients of both companies can expect a seamless transition
during the integration of the two companies and can continue to
contact their current representatives for support needs.
About Linus Health
Linus Health is a Boston-based digital health company focused on
transforming brain health for people across the world. By advancing
how we detect and address cognitive and brain disorders –
leveraging cutting-edge neuroscience, clinical expertise, and
artificial intelligence – our goal is to enable a future where
people can live longer, happier, and healthier lives with better
brain health. Linus Health's digital cognitive assessment platform
delivers a proven, practical means of enabling early detection;
empowers providers with actionable clinical insights; and supports
individuals with personalized action plans. We are proud to partner
with leading healthcare delivery organizations, research
institutions, and life sciences companies to accelerate more
proactive intervention and personalized care in brain health. To
learn more about our practical solutions for proactive brain
health®, visit www.linushealth.com or follow us on
LinkedIn.
Media Contact
Tara
Stultz (Amendola for Linus Health)
440-225-9595
tstultz@acmarketingpr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/linus-health-acquires-aural-analytics-302084746.html
SOURCE Linus Health